Scholar Rock (NASDAQ: SRRK)
Scholar Rock Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Scholar Rock Company Info
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
News & Analysis
Why Scholar Rock Stock Wilted on Wednesday
The market was hoping the company could better contain its losses.
Scholar Rock (SRRK) Q2 Loss Widens 63%
Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year
Why Scholar Rock Shares Are Soaring Today
Why Scholar Rock Holding Stock Topped the Market Today
Here's Why Everybody's Talking About Scholar Rock Right Now
Successful clinical-trial results recently made Scholar Rock one of the stock market's top performers.
Why Scholar Rock Holding Stock Soared Today
The market celebrated Scholar Rock's upsized stock offering and plans to advance development of a new obesity treatment. Here's what investors need to know.
Why Scholar Rock Stock Flew High Today
A venture capital group significantly increased its stake in the company.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.